中国·手机球探(bet007认证)官方网站-Macau App Station

Research platforms

Early druggability assessment stage

PLATFORM

ABOUT US SERVICES PLATFORM CAREERS NEWS INFORMATION DISCLOSURE CONTACT US

Early druggability assessment stage

Early-stage toxicity prediction and screening

Early efficacy screening Early pharmacoscreening Early-stage toxicity prediction and screening Isotope labeling and imaging

Early-stage toxicity prediction and screening

-High-throughput genotoxicity screening

In vitro cardiotoxicity evaluation
-Ion channels (hERG, Nav 1-5, Ca v 1-2)
-Real-time Cell Analysis (RTCA)
-In vitro screening of differentiated cardiomyocytes induced by hiPSC

In vitro prediction of carcinogenicity
-In vitro phototoxicity evaluation
-Phototoxic red-neutral uptake assay in 3T3 cells

Evaluation of high-throughput reproductive developmental toxicity
-Whole-embryo culture in vitro
-Screening for developmental toxicity in zebrafish embryos

General toxicity screening in vivo
-Single / repeated dose toxicity exploratory test study
-Safety evaluation of the drug product

For more information, please contact us.

+86-021-60211999

MESSAGE

Business requirements

The content of the business requirements drop-down menu is as follows

Early-stage Druggability Assessment Pharmacodynamics Nonclinical pharmacokinetics Toxicology (Safety evaluation) Clinical biological sample testing Biomarkers and translational research Global registration and consultation services

Consultation product molecular type

Message content

Shanghai Headquarters

Address: 199 Guoshoujing Road, Pilot Free Trade Zone, Shanghai, China

Postcode: 201203

Tel: +86-21-60211999
Contact us

services@innostar.cn
投资者关系

86-021-xxxxxxx

Scan the QR code
Subscription to our Wechat account